70%-80% Drop In Participation For Phase 3 Trials Of Covaxin: Official The refusal rate of phase-3 trial is much higher than for phase 1 and phase 2 trials, which was less than 10 per cent, he said.
Updated: December 17, 2020 4:37 pm IST
The refusal rate of phase-3 trial is much higher than for phase 1 and phase 2 trials, Dr Sanjay Rai said.
New Delhi:
Despite phase-1 trial of its Covaxin vaccine seeing encouraging results, Hyderabad-based Bharat Biotech is facing challenges in phase 3 trials of its vaccine in India, a top official associated with the project told NDTV.
The drugmaker has witnessed 70%-80% reduction in participation for Covaxin trial, according to Dr Sanjay Rai who is Principal Investigator of Phase 3 Covaxin trial at AIIMS.
Updated Dec 17, 2020 | 15:22 IST
Dr Sanjay Rai, Principal Investigator of COVAXIN trial at AIIMS Delhi said the enthusiasm which was seen in earlier two trials is missing in the third phase. Volunteers count dips in Covaxin Phase-3 trials at AIIMS
Key Highlights
Rai said in the Phase-3 trials about 70 to 80 per cent refusal rate has been seen in participation, whereas refusal rate was less than 10 per cent for phase 1 and 2 trial.
Volunteers when informed that they may also be given placebo as it s a trial phase, refuse for participation, he said.
New Delhi: The subject enrollment for Phase-3 human trial of indigenous COVAXIN has seen a decline in All India Institute of Medical Sciences (AIIMS), New Delhi, as over 70 per cent volunteers refused to take shots after participating in the trial.
COVID-positive Haryana Minister Anil Vij admitted to Gurugram Hospital in critical condition
Haryana Health Minister Anil Vij, who is currently battling the Covid-19 infection, was on Tuesday admitted to Gurugram s Medanta Hospital in a critical condition, officials said.
By IANS
Anil Vij Haryana Health Minister gets a trial dose of Covaxin.
Haryana Health Minister Anil Vij, who is currently battling the Covid-19 infection, was on Tuesday admitted to Gurugram s Medanta Hospital in a critical condition, officials said.
The minister is getting treatment under Dr Sushila Kataria, senior director of Internal Medicine Department at Medanta, adding that the minister is suffering from a lung infection.
Covid-positive Indian minister who got vaccine admitted to hospital in critical condition
IANS/New Delhi
Photo: ANI
Haryana Health Minister Anil Vij had moderate Covid-19 with bilateral viral pneumonia.
Haryana Health Minister Anil Vij, who is currently battling the Covid-19 infection, was on Tuesday admitted to Gurugram s Medanta Hospital in a critical condition, officials said.
The minister is getting treatment under Dr Sushila Kataria, senior director of Internal Medicine Department at Medanta, sources told IANS, adding that the minister is suffering from lung infection.
However, there was no official response from the hospital.
Vij was admitted to Medanta in the evening from the Haryana government s Post-Graduate Institute of Medical Sciences (PGIMS) in Rohtak where he was admitted on Saturday and had received convalescent plasma therapy. The institute had stated that Vij had moderate Covid-19 with bilateral viral pneumonia.
The health ministry said that the equipment had already been delivered to the states. Dec 16, 2020 · 08:43 am File photo: A research scientist works inside a laboratory of the Serum Institute in Pune, | Euan Rocha/ Reuters
The Ministry of Health and Family Welfare on Tuesday detailed the Centre’s plan for storing coronavirus vaccines as it prepares for a massive inoculation drive.
Union Health Secretary Rajesh Bhushan said at a press briefing that the storage arrangements would include 29,000 cold chain points, 240 walk-in coolers, 70 walk-in freezers, 45,000 ice-lined refrigerators, 41,000 deep freezers and 300 solar refrigerators.
The health secretary said that the equipment had already been delivered to states, according to PTI. He added that all states and Union territories have concluded vaccination-related meetings with State Steering Committees and State Task Force.